Abstract
The total synthesis of leiodermatolide A was accomplished in 13 steps (LLS). Transfer hydrogenative variants of three carbonyl additions that traditionally rely on premetalated reagents (allylation, crotylation and propargylation) are deployed together in one total synthesis.
Graphical Abstract

Natural products that disrupt microtubule dynamics have found broad use as anti-cancer agents.1 Leiodermatolide A is an antimitotic marine macrolide that was isolated in 2008 from crude extracts of a deep sea lithistid sponge of the genus Leiodermatium found off the Florida coast (Figure 1).2 In a panel of human cancer cell lines, leiodermatolide A exhibited potent antiproliferative effects, selectively perturbing tubulin dynamics at nM concentrations through a novel mechanism: while incurring abnormal spindle formation at nM concentrations in two different cancer cell lines, purified tubulin remained undisturbed in vitro even at much higher concentrations.2,3 The scarce supply and compelling biology of leiodermatolide A has driven efforts toward its de novo chemical synthesis, resulting in truly impressive total syntheses by Paterson4 and Fürstner5 and substructure syntheses by Maier.6 The synthesis of leiodermatolide analogues5b,c,6d have led to additional biological data that reveal mitotic arrest, micronucleus induction, centrosome amplification and tubulin disruption in human U2OS cells without evidence for direct binding of tubulin in cell-free analyses.5b Based on these data, centrosome declustering was suggested as a possible mechanism of action.7 Further investigations into leiodermatolide’s unique biology have been prohibited due to lack of material.
Figure 1.

Structures of Leiodermatolides A-C, Prior Total Syntheses and Retrosynthetic Analysis.a
aFor graphical summaries of prior total syntheses, see Supporting Information. Longest Linear Sequence (LLS); Total Steps (TS). Only transformations in the longest linear sequence (LLS) are considered in the analysis of reaction type.
The issues surrounding leiodermatolide A are emblematic of the persistent challenges associated with the construction of structurally complex secondary metabolites that continue to evoke innovation across the field of chemical synthesis. In the specific context of type I polyketides, which are ubiquitous in human medicine,8 commercial manufacturing routes rarely exploit de novo chemical synthesis, highlighting the need for more efficient and process-relevant synthetic methods. Inspired by the broad use of hydrogenation and transfer hydrogenation in the production of clinical candidates, we have advanced a suite of catalytic enantioselective carbonyl reductive couplings based on alcohol mediated hydrogen transfer.9,10 Using these methods, an initial (but unsuccessful) campaign toward leiodermatolide A was undertaken.11 Here, we disclose a more fruitful approach employing catalytic enantioselective transfer hydrogenative allylation,12a,b crotylation12c,d,e and propargylation12f,13 that has resulted in a 13 step (LLS) total synthesis of leiodermatolide A, constituting the most concise route to this compound reported, to date.
Retrosynthetically, leiodermatolide A was envisioned to arise through a polyconvergent assembly of Fragments A, B and C (Figure 1). Fragment A is accessible through the Hosomi-Sakurai reaction14 of aldehyde 8 (prepared by catalytic enantioselective transfer hydrogenative crotylation of acetylentic aldehyde 5),12e with allylsilane 4 (prepared by enantioselective transfer hydrogenative allylation of tiglic aldehyde 1).11,12a,b,c Fragment B is generated via transfer hydrogenative carbonyl propargylation employing an enyne pronucleophile.12f,13 Finally, Fragment C is prepared by Mukaiyama aldol reaction of phenyl acrylate 11 with propanal 12 to give the anti-aldol15,16 followed by kinetic resolution via asymmetric acetylation using Birman’s catalyst,17 and then Dieckmann condensation-ketone allylboration.5b,18
The synthesis of Fragment A begins with the conversion of tiglic aldehyde 1 to allyl silane 4 (Scheme 1).11 Using 1.25 mol % loadings of the π-allyliridium-C,O-benzoate modified by (S)-BINAP, 2-propanol-mediated reductive coupling of tiglic aldehyde 1 with allyl acetate delivers the homoallylic alcohol 2 in 78% yield and 92% ee.12a,b As shown, the chromatographically stable iridium catalyst could be recovered in 39% yield and recycled without erosion in performance. Conversion of alcohol 2 to aldehyde 3 is achieved via benzoylation of secondary alcohol followed by chemoselective anti-Markovnikov Wacker oxidation19 of the less substituted olefin. Aldehyde 3 is transformed to allyl silane 4 as described via Pinnick oxidation,20 treatment of the resulting carboxylic acid with TMS-diazomethane,21 and silylzinc-mediated regio- and stereospecific copper-catalyzed allylic substitution, as described by Oestereich.22 Aldehyde 8 is prepared through transfer hydrogenative crotylation of acetylenic aldehyde 512c,d,e followed by Mitsunobu inversion-saponification23 to furnish 1,5-enyne 7. Conversion of 7 to the TOM ether (iPr3SiOCH2)24 followed by ozonolysis delivers aldehyde 8. With allyl silane 4 and aldehyde 8 in hand, Hosomi-Sakurai reaction14 was attempted. Upon evaluation of different Lewis acids,11 it was found that chelation-controlled addition could be achieved in 62% yield using AlEtCl2 (250 mol %). Exhaustive deprotection of the Hosomi-Sakurai product delivers Fragment A.
Scheme 1.

Preparation of Fragment A via Catalytic Enantioselective Transfer Hydrogenative Carbonyl Allylation and Crotylation.
aYields are of material isolated by silica gel chromatography. Diastereoselectivities were determined by 1H NMR of crude reaction mixtures. Enantioselectivities were determined by chiral stationary phase HPLC analysis. TTMPP = Tris(2,4,6-trimethoxyphenyl)phosphine. See Supporting Information for experimental details.
Fragment B is prepared via iridium-catalyzed enyne-mediated propargylation of dienol 10 (Eq. 1),12f,13 which is a known compound accessible in 2 steps from crotonaldehyde.25 The reported method for propargylation utilized an enyne substituted by (TIPSO)Me2C. However, it was anticipated that the δ-lactone of leiodermatolide A would not tolerate conditions required for deprotection of this group (which involves base-mediated elimination of acetone). Hence, the indicated triisopropylsilyl terminated enyne 9 was used and, to our delight, good levels of diastereo- and enantioselectivity were observed.
![]() |
(Eq. 1) |
The synthesis of Fragment C, which incorporates the δ-lactone of leiodermatolide A, is accomplished in 5 steps (Scheme 2). The δ-lactone of leiodermatolide A was previously prepared by Fürstner using a chiral enolate modified by Evan’s auxiliary.5 Direct catalytic enantioselective aldol addition of a propionate ester such as 11 with propanal 12 would avoid manipulations associated with the preparation, installation and removal of an auxiliary, yet aldol additions of this type remain an unmet challenge. Kinetic resolution of the racemic aldol rac-13, which is accessible via anti-diastereoselective Mukaiyama aldol addition,15,16 was deemed an attractive alternative, as the resulting acetate could be directly subjected to Dieckmann condensation to deliver the cyclic β-ketoester 14. Using Birman’s catalyst,17 (R)-HBTM, formation of the acetate was realized with useful levels of selectivity and, therefrom, enantiomerically enriched β-ketoester 14 was made. BINOL-catalyzed allylboration of β-ketoester 145b,18 completes the synthesis of Fragment C. Upon use of racemic 3,3′-Br2-BINOL as catalyst, a 1:3 diastereomeric ratio was observed in favor of the opposite stereoisomer, indicating that the asymmetric allylation used to form Fragment C represents the mismatched case.
Scheme 2.

Preparation of Fragment C via Kinetic Resolution of anti-Aldol 13 Using Birman’s Catalyst.a
aDiastereoselectivities were determined by 1H NMR of crude reaction mixtures. Enantioselectivities were determined by chiral stationary phase HPLC analysis.
With Fragments A, B and C in hand, the total synthesis of leiodermatolide A was undertaken (Scheme 3). The union of Fragment B and C is achieved via cross-metathesis using the second generation Hoveyda-Grubbs catalyst. The alkyne moiety present in Fragment B made this transformation challenging, yet dienyne 15 could be formed in 47% yield along with a dimer derived from Fragment C (that could be subjected to cross-metathesis with Fragment B to provide 15 in comparable yield). Conversion of 15 to the cis-vinyl iodide 16 was accomplished in a three step sequence involving silyl-deprotection of the TIPS alkyne, NIS-mediated iodination of the resulting terminal alkyne,26 and diimide reduction of the acetylenic iodide to the cis-vinyl iodide 16 using NBSH.27 Sonogashira coupling of equimolar quantities of cis-vinyl iodide 16 and Fragment A occurred in the presence of the free carboxylic acid28 to deliver the conjugated enyne 17 in 60% yield. Yamaguchi lactonization29 of compound 17 occurred in remarkably high yield despite the presence of multiple unprotected hydroxyl groups. Several methods for semi-hydrogenation of the macrocyclic enyne were explored, including Zn(Cu/Ag) amalgam as described by Fürstner.4 In our hands, these methods were problematic due to over-reduction accompanied by isomerization of the initially formed cis,cis-diene. We eventually found that semi-hydrogenation using a cationic rhodium catalyst provided the most reliable results.30,31 It should be noted that our cis,cis-diene is identical to material prepared by Paterson, who found that treatment of the C7,C9-diol with Cl3CC(O)NCO resulted in a 4:1 ratio of the C7 and C9 carbamates (favoring the undesired isomer).5 In a model system, we found the regioselectivity of carbamoylation could be inverted upon pretreatment with 9-BBN (Eq. 2).32 This effect was less pronounced in the carbamoylation en route to leiodermatolide A, but still availed an improvement relative to the intrinsic bias of the system, enabling access to leiodermatolide A in 13 steps (LLS) – the most concise synthesis of leiodermatolide A reported, to date.
Scheme 3.

Union of Fragments A, B and C and Total Synthesis of Leiodermatolide A.a
aYields are of material isolated by silica gel chromatography. See Supporting Information for experimental details.
![]() |
(Eq. 2) |
To conclude, the synthetic challenges posed by the structural complexity of polyketide natural products have evoked numerous advances in acyclic stereocontrol, especially in the context of carbonyl addition. Whereas the initial lexicon of asymmetric methods that emerged focused on the use of premetalated C-nucleophiles and chiral auxiliaries, we aim to advance a suite of catalytic enantioselective C-C couplings that bypass discrete organometallic reagents and stoichiometric chiral inducing elements. The present total synthesis of leiodermatolide A, which exploits asymmetric alcohol-mediated allylation, crotylation and propargylation, exemplifies how time-honored transformations that have traditionally relied on premetalated reagents can now be conducted catalytically from tractable π-unsaturated pronucleophiles.
Supplementary Material
Acknowledgments.
The Robert A. Welch Foundation (F-0038), and the NIH-NIGMS (R01 GM093905, 1 S10 OD021508-01) are acknowledged for financial support. We thank Dr. Julian Wippich and Dr. Stephen D. Ramgren for efforts toward our first-generation route to leiodermatolide A (ref. 11).
Footnotes
Supporting Information Available: Experimental procedures and spectral data for all new compounds. This material is available free of charge via the internet at http://pubs.acs.org.
The authors declare no competing financial interest.
REFERENCES
- (1).For selected reviews on anti-cancer agents that perturb microtubule dynamics, see:, see:; (a) Jordan MA; Wilson L Microtubules as a Target for Anticancer Drugs. Nat. Rev. Cancer 2004, 4, 253–265. [DOI] [PubMed] [Google Scholar]; (b) Altmann K-H; Gertsch J Anticancer Drugs from Nature – Natural Products as a Unique Source of New Microtubule-Stabilizing Agents. Nat. Prod. Rep 2007, 24, 327–357. [DOI] [PubMed] [Google Scholar]; (c) Dumontet C; Jordan MA Microtubule-Binding Agents: A Dynamic Field of Cancer Therapeutics. Nat. Rev. Drug Discovery 2010, 9, 790–803. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Rohena CC; Mooberry SL Recent Progress with Microtubule Stabilizers: New Compounds, Binding Modes and Cellular Activities. Nat. Prod. Rep 2014, 31, 335–355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (2).For isolation and partial structure determination of leiodermatolides A and B, see:; (a) Wright AE; Reed JK; Roberts J; Longley RE. Antiproliferative Activity of The Leiodermatolide Class of Macrolides. U. S. Pat. Appl. Publ. US 20080033035 A1 20080207, 2008.; (b) Paterson I; Dalby SM; Roberts JC; Naylor GJ; Guzmán EA; Isbrucker R; Pitts TP; Linley P; Divlianska D; Reed JK; Wright AE Leiodermatolide, a Potent Antimitotic Macrolide from The Marine Sponge Leiodermatium sp.. Angew. Chem. Int. Ed 2011, 50, 3219–3223. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Wright AE; Roberts JC; Guzmán EA; Pitts TP; Pomponi SA; Reed JK. Analogues of the Potent Antitumor Compound Leiodermatolide from a Deep-Water Sponge of the Genus Leiodermatium. J. Nat. Prod 2017, 80, 735–739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (3).Guzman EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE Leiodermatolide, a Novel Marine Natural Product, has Potent Cytotoxic and Anti-Mitotic Activity Against Cancer Cells, Appears to Affect Microtubule Dynamics, and Exhibits Anti-Tumor Activity. Int. J. Cancer 2016, 139, 2116–2126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (4).For work on leiodermatolide from the Paterson laboratory, see:; (a) Paterson I; Paquet T; Dalby SM Synthesis of the Macrocyclic Core of Leiodermatolide. Org. Lett 2011, 13, 4398–4401. [DOI] [PubMed] [Google Scholar]; (b) Paterson I; Ng KK-H; Williams S; Millican DC; Dalby SM Total Synthesis of the Antimitotic Marine Macrolide (-)-Leiodermatolide. Angew. Chem., Int. Ed 2014, 53, 2692–2695. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Paterson I; Williams S Strategy Evolution in the Total Synthesis of (−)-Leiodermatolide. Isr. J. Chem 2017, 57, 192–201. [Google Scholar]
- (5).For work on leiodermatolide from the Fürstner laboratory, see:; (a) Willwacher J; Kausch-Busies N; Fürstner A Divergent Total Synthesis of the Antimitotic Agent Leiodermatolide. Angew. Chem., Int. Ed 2012, 51, 12041–12046. [DOI] [PubMed] [Google Scholar]; (b) Mailhol D; Willwacher J; Kausch-Busies N; Rubitski EE; Sobol Z; Schuler M; Lam M-H; Musto S; Loganzo F; Maderna A; Fürstner A Synthesis, Molecular Editing, and Biological Assessment of the Potent Cytotoxin Leiodermatolide. J. Am. Chem. Soc 2014, 136, 15719–15729. [DOI] [PubMed] [Google Scholar]; (c) Fürstner A; Mailhol D; Willwacher J Leiodermatolide Derivatives and Their Use. Eur. Pat. Appl. EP 3012257 A1 20160427, 2016.
- (6).For work on leiodermatolide from the Maier laboratory, see:; (a) Navickas V; Rink C; Maier ME Synthetic Studies towards Leiodermatolide: Rapid Stereoselective Syntheses of Key Fragments. Synlett 2011, 191–194. [Google Scholar]; (b) Rink C; Navickas V; Maier ME An Approach to the Core Structure of Leiodermatolide. Org. Lett 2011, 13, 2334–2337. [DOI] [PubMed] [Google Scholar]; (c) Reiss A; Maier ME Toward Leiodermatolide: Synthesis of the Core Structure. Org. Lett 2016, 18, 3146–3149. [DOI] [PubMed] [Google Scholar]; (d) Reiss A; Maier ME Synthesis of a Leiodermatolide Analogue with a Dienyl Side Chain. Eur. J. Org. Chem 2018, 4246–4255. [Google Scholar]
- (7).For reviews on the relationship between centrosomes and cancer, see:; (a) Gonczy P. Centrosomes and Cancer: Revisiting a Long-Standing Relationship. Nat. Rev. Cancer 2015, 15, 639–652. [DOI] [PubMed] [Google Scholar]; (b) Milunovic-Jevtic A; Mooney P; Sulerud T; Bisht J; Gatlin JC Centrosomal Clustering Contributes to Chromosomal Instability and Cancer. Curr. Opin. Biotechnol 2016, 40, 113–118. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Ansari D; Del Pino Bellido C; Bauden M; Andersso R Centrosomal Abnormalities in Pancreatic Cancer: Molecular Mechanisms and Clinical Implications. Anticancer Res. 2018, 38, 1241–1245. [DOI] [PubMed] [Google Scholar]; (d) LoMastro GM; Holland AJ The Emerging Link between Centrosome Aberrations and Metastasis. Devel. Cell 2019, 49, 325–331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).For reviews on polyketide natural products in human medicine, see:; (a) Rohr J A New Role for Polyketides. Angew. Chem. Int. Ed 2000, 39, 2847–2849. [DOI] [PubMed] [Google Scholar]; (b) Newman DJ; Cragg GM Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019 J. Nat. Prod 2020, 83, 770–803. [DOI] [PubMed] [Google Scholar]
- (9).For recent reviews on hydrogen-mediated carbonyl reductive coupling, see:; (a) Nguyen KD; Park BY; Luong T; Sato H; Garza VJ; Krische MJ Metal-Catalyzed Reductive Coupling of Olefin-Derived Nucleophiles: Reinventing Carbonyl Addition. Science 2016, 354, aah5133–1–aah5133–6. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Kim SW; Zhang W; Krische MJ Catalytic Enantioselective Carbonyl Allylation and Propargylation via Alcohol-Mediated Hydrogen Transfer: Merging the Chemistry of Grignard and Sabatier. Acc. Chem. Res 2017, 50, 2371–2380. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Holmes M; Schwartz LA; Krische MJ Intermolecular Metal-Catalyzed Reductive Coupling of Dienes, Allenes and Enynes with Carbonyl Compounds and Imines. Chem. Rev 2018, 118, 6026–6052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (10).For reviews encompassing application of hydrogenative C-C coupling to polyketide construction, see:; (a) Dechert-Schmitt A-MR; Schmitt DC; Gao X; Itoh T; Krische MJ Polyketide Construction via Hydrohydroxyalkylation and Related Alcohol C–H Functionalizations: Reinventing The Chemistry of Carbonyl Addition. Nat. Prod. Rep 2014, 31, 504–513. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Feng J; Kasun ZA; Krische MJ Enantioselective Alcohol C–H Functionalization for Polyketide Construction: Unlocking Redox-Economy and Site-Selectivity for Ideal Chemical Synthesis. J. Am. Chem. Soc 2016, 138, 5467–5478. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Liu H; Lin S; Jacobsen KM; Poulsen TB Chemical Syntheses and Chemical Biology of Carboxyl Polyether Ionophores: Recent Highlights. Angew. Chem. Int. Ed 2019, 58, 13630–13642. [DOI] [PubMed] [Google Scholar]; (d) Doerksen RS; Meyer CC; Krische MJ Feedstock Reagents in Metal-Catalyzed Carbonyl Reductive Coupling: Minimizing Preactivation for Efficiency in Target-Oriented Synthesis. Angew. Chem. Int. Ed 2019, 58, 14055–14064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (11).Roane J; Wippich J; Ramgren SD; Krische MJ Synthesis of the C(1)-C(13) Fragment of Leiodermatolide via Hydrogen-Mediated C-C Bond Formation. Org. Lett 2017, 19, 6634–6637. [DOI] [PMC free article] [PubMed] [Google Scholar]; The strategy depicted Figure 1 of this report was abandoned due to an inability to form the C12-C13 olefin via (Z)-selective cross-metathesis in the presence of the C14 methyl group. In the absence of the C14 methyl group, the product of (Z)-selective cross-metathesis was formed in 45% yield.
- (12).For transfer hydrogenative allylation, crotylation and propargylation, see:; (a) Kim IS; Ngai M-Y; Krische MJ Enantioselective Iridium Catalyzed Carbonyl Allylation from the Alcohol or Aldehyde Oxidation Level Using Allyl Acetate as an Allyl Metal Surrogate. J. Am. Chem. Soc 2008, 130, 6340–6341. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Kim IS; Ngai M-Y; Krische MJ Enantioselective Iridium Catalyzed Carbonyl Allylation from the Alcohol or Aldehyde Oxidation Level via Transfer Hydrogenative Coupling of Allyl Acetate: Departure from Chirally Modified Allyl Metal Reagents in Carbonyl Addition. J. Am. Chem. Soc 2008, 130, 14891–14899. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Kim IS; Han SB; Krische MJ anti-Diastereo- and Enantioselective Carbonyl Crotylation from the Alcohol or Aldehyde Oxidation Level Employing a Cyclometallated Iridium Catalyst: α-Methyl Allyl Acetate as a Surrogate to Preformed Crotylmetal Reagents. J. Am. Chem. Soc 2009, 131, 2514–2520. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Gao X; Townsend IA; Krische MJ Enhanced anti-Diastereo- and Enantioselectivity in Alcohol Mediated Carbonyl Crotylation Using an Isolable Single Component Iridium Catalyst. J. Org. Chem 2011, 76, 2350–2354. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Brito GA; Della-Felice F; Luo G; Burns AS; Pilli R; Rychnovsky SD; Krische MJ Catalytic Enantioselective Allylations of Acetylenic Aldehydes via 2-Propanol-Mediated Reductive Coupling. Org. Lett 2018, 20, 4144–4147. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Geary LM; Woo SK; Leung JC; Krische MJ Diastereo- and Enantioselective Iridium Catalyzed Carbonyl Propargylation from the Alcohol or Aldehyde Oxidation Level: 1,3-Enynes as Allenylmetal Equivalents. Angew. Chem. Int. Ed 2012, 51, 2972–2976. [DOI] [PubMed] [Google Scholar]
- (13).For a recent application of catalytic enantioselective enyne-mediated carbonyl propargylation in polyketide total synthesis, see:; Schulthoff S; Hamilton JY; Heinrich M; Kwon Y; Wirtz C Fürstner, A. The Formosalides: Structure Determination by Total Synthesis. Angew. Chem. Int. Ed 2021, 60, 446–454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (14).For reviews on chiral allylsilanes in Hosomi-Sakurai allylation, see:; (a) Masse CE; Panek JS Diastereoselective Reactions of Chiral Allyl- and Allenylsilanes with Activated C=X π-Bonds. Chem. Rev 1995, 95, 1293–1316. [Google Scholar]; (b) Lee JH Use of the Hosomi-Sakurai Allylation in Natural Product Total Synthesis. Tetrahedron 2020, 76, 131351. [Google Scholar]
- (15).Saigo K; Osaki M; Mukaiyama T A New Method for the Preparation of β-Hydroxyesters. The Titanium Tetrachloride-Promoted Reaction of Ketene Alkyl Trialkylsilyl Acetals with Carbonyl Compounds. Chem. Lett 1975, 989–990. [Google Scholar]
- (16).For closely related aldol additions, see:; (a) Gennari C; Bernardi A; Columbo L; Scolastico C Enantioselective Synthesis of anti-α-Methyl-β-Hydroxy Esters through TiCl4-Mediated Aldol Condensation. J. Am. Chem. Soc 1985, 107, 5812–5813. [Google Scholar]; (b) Cheskis BA; Moiseenkov AM; Shpiro NA; Stashina GA; Zhulin VM Stereochemically Controlled Synthesis of Racemic Sitophilate, The Aggregation Pheromone of the Grain Weevil. Bull. Acad. Sci, USSR CH 1991, 40, 2205–2211. [Google Scholar]
- (17).To our knowledge, the preparation of Fragment C represents the first non-enzymatic kinetic resolution of an aldol. The fractional crystallization of 14 is unoptimized:; Li X; Jiang H; Uffman EW; Guo L; Zhang Y; Yang X; Birman VB Kinetic Resolution of Secondary Alcohols Using Amidine-Based Catalysts. J. Org. Chem 2012, 77, 1722–1737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (18).(a) Lou S; Moquist PN; Schaus SE Asymmetric Allylboration of Ketones Catalyzed by Chiral Diols. J. Am. Chem. Soc 2006, 128, 12660–12661. [DOI] [PubMed] [Google Scholar]; (b) Barnett DS; Moquist PN; Schaus SE The Mechanism and an Improved Asymmetric Allylboration of Ketones Catalyzed by Chiral Biphenols. Angew. Chem. Int. Ed 2009, 48, 8679–8682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (19).Wickens ZK; Skakuj K; Morandi B; Grubbs RH Catalyst-Controlled Wacker-Type Oxidation: Facile Access to Functionalized Aldehydes. J. Am. Chem. Soc 2014, 136, 890–893. [DOI] [PubMed] [Google Scholar]
- (20).(a) Bal BS; Childers WE Jr.; Pinnick HW Oxidation of α,β-Unsaturated Aldehydes. Tetrahedron 1981, 37, 2091–2096. [Google Scholar]; (b) Lei A; Porco JA Jr. Total Synthesis of the Diazobenzofluorene Antibiotic (-)-Kinamycin C. J. Am. Chem. Soc 2006, 128, 14790–14791. [DOI] [PubMed] [Google Scholar]
- (21).Seyferth D; Dow AW; Menzel H; Flood TC Trimethylsilyldiazomethane and Trimethylsilylcarbene. J. Am. Chem. Soc 1968, 90, 1080–1082. [Google Scholar]
- (22).Schmidtmann ES; Oestereich M Mechanistic Insight into Copper-Catalysed Allylic Substitutions with bis(Triorganosilyl) Zincs. Enantiospecific Preparation of α-Chiral Silanes. Chem. Commun 2006, 3643–3645. [DOI] [PubMed] [Google Scholar]
- (23).Martin SF; Dodge JA Efficacious Modification of The Mitsunobu Reaction for Inversions of Sterically Hindered Secondary Alcohols. Tetrahedron Lett. 1991, 32, 3017–3020. [Google Scholar]
- (24).Pitsch S; Weiss PA; Jenny L; Stutz A; Wu X Reliable Chemical Synthesis of Oligoribonucleotides (RNA) with 2′-O-[(Triisopropylsilyl)oxy]methyl(2′-O-tom)-Protected Phosphoramidites. Helv. Chim. Acta 2001, 84, 3773–3795. [Google Scholar]
- (25).Piers E; Jung GL; Ruediger EH Synthesis of Functionalized Bicyclo[3.2.l]octa-2,6-dienes by Thermal Rearrangement of Substituted 6-exo-(1-Alkenyl)bicyclo[3.1 .O]hex-2-ene Systems. Can. J. Chem 1987, 65, 670–682. [Google Scholar]
- (26).Li M; Li Y; Zhao B; Liang F; Jin L-Y Facile and Efficient Synthesis of 1-Haloalkynes via DBU-Mediated Reaction of Terminal Alkynes and N-Haloimides under Mild Conditions. RSC Adv. 2014, 4, 30046–30049. [Google Scholar]
- (27).(a) Luethy C; Konstantin P; Untch KG Total Synthesis of dl-19-Hydroxyprostaglandin E1 and dl-13-cis-15-epi-19-Hydroxyprostaglandin E1. J. Am. Chem. Soc 1978, 100, 6211–6217. [Google Scholar]; (b) Myers AG; Zheng B; Movassaghi M Preparation of the Reagent o-Nitrobenzenesulfonylhydrazide. J. Org. Chem 1997, 62, 7507. [DOI] [PubMed] [Google Scholar]
- (28).Park K; You J-M; Jeon S; Lee S Palladium-Catalyzed Sonogashira Reaction for the Synthesis of Arylalkynecarboxylic Acids from Aryl Bromides at Low Temperature. Eur. J. Org. Chem 2013, 1973–1978. [Google Scholar]
- (29).Inanaga J; Hirata K; Saeki H; Katsuki T; Yamaguchi M A Rapid Esterification by Means of Mixed Anhydride and Its Application to Large-ring Lactonization. Bull. Chem. Soc. Jpn 1979, 52, 1989–1993. [Google Scholar]
- (30).(a) Schrock RR; Osborn JA Catalytic Hydrogenation using Cationic Rhodium Complexes. II. The Selective Hydrogenation of Alkynes to cis Olefins. J. Am. Chem. Soc 1976, 98, 2143–2147. [Google Scholar]; (b) Schrock RR; Osborn JA Catalytic hydrogenation using Cationic Rhodium Complexes. 3. The Selective Hydrogenation of Dienes to Monoenes. J. Am. Chem. Soc 1976, 98, 4450–4455. [Google Scholar]
- (31).Huddleston RR; Jang H-Y; Krische MJ First Catalytic Reductive Coupling of 1,3-Diynes to Carbonyl Partners: A New Regio- and Enantioselective C–C Bond Forming Hydrogenation. J. Am. Chem. Soc 2003, 125, 11488–11489. [DOI] [PubMed] [Google Scholar]
- (32).It was posited that the more reactive hydroxyl group of the diol (that delivers the undesired isomer) would be selectively protected as the borinate ester:; Yang L; Lin Z; Shao S; Zhao Q; Hong R An Enantioconvergent and Concise Synthesis of Lasonolide A. Angew. Chem. Int. Ed 2018, 57, 16200–16204. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


